Calamos Advisors
AMED

Calamos Advisors’s Amedisys AMED Stock Holding History

Calamos Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-409,603
Closed -$40.3M – 921
2025
Q2 		$40.3M Sell
409,603
-77,841
-16% -$7.36M 0.16% 146
2025
Q1 		$45.2M Hold
487,444
– – 0.2% 121
2024
Q4 		$44.3M Buy
487,444
+90,097
+23% +$8.27M 0.19% 123
2024
Q3 		$38.3M Hold
397,347
– – 0.17% 145
2024
Q2 		$36.5M Buy
397,347
+41,220
+12% +$3.82M 0.16% 146
2024
Q1 		$32.8M Buy
356,127
+114,017
+47% +$10.7M 0.16% 176
2023
Q4 		$23M Buy
+242,110
New +$22.6M 0.11% 226
2021
Q2 		– Sell
-3,434
Closed -$909K – 955
2021
Q1 		$909K Sell
3,434
-4,439
-56% -$1.25M 0.01% 801
2020
Q4 		$2.31M Sell
7,873
-2,531
-24% -$649K 0.01% 624
2020
Q3 		$2.46M Buy
10,404
+3,097
+42% +$704K 0.02% 572
2020
Q2 		$1.45M Sell
7,307
-27,972
-79% -$5.22M 0.01% 604
2020
Q1 		$6.47M Sell
35,279
-6,379
-15% -$1.13M 0.05% 352
2019
Q4 		$6.95M Sell
41,658
-126
-0.3% -$18.7K 0.03% 448
2019
Q3 		$5.47M Buy
41,784
+782
+2% +$102K 0.03% 494
2019
Q2 		$4.98M Buy
+41,002
New +$4.87M 0.03% 525
2019
Q1 		– Sell
-3,500
Closed -$410K – 656
2018
Q4 		$410K Buy
+3,500
New +$413K ﹤0.01% 597

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Calamos Advisors's AMED Position: Q3 2025 in Review

Calamos Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 409,603 shares — an estimated $40.3M sold.

Calamos Advisors first reported a position in AMED in Q4 2018 and held it in 16 quarters. The position peaked at $45.2M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Calamos Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Calamos Advisors sold 409,603 Amedisys shares in Q3 2025, an estimated $40.3M.
  • Calamos Advisors first reported a position in Amedisys in Q4 2018 and held it in 16 quarters.
  • Calamos Advisors's Amedisys position peaked at $45.2M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Calamos Advisors's 13F filing for Q3 2025, filed 20 Oct 2025.